Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 1992-03-26 (34 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PIERRELATTE (26700), Drome
PHARMACIE CROIX D'OR : revenue, balance sheet and financial ratios
PHARMACIE CROIX D'OR is a French company
founded 34 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PIERRELATTE (26700),
this company of category PME
shows in 2019 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CROIX D'OR (SIREN 385092390)
Indicator
2025
2024
2023
2022
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
1 250 112 €
1 301 762 €
1 396 983 €
Net income
253 238 €
141 987 €
165 491 €
620 724 €
34 964 €
74 353 €
53 722 €
EBITDA
N/C
N/C
N/C
N/C
58 533 €
104 144 €
88 983 €
Net margin
N/C
N/C
N/C
N/C
2.8%
5.7%
3.8%
Revenue and income statement
In 2025, PHARMACIE CROIX D'OR generates positive net income of 253 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 54 k€ -> 253 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
253 238 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 45%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
45.206%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2022
2023
2024
2025
Debt ratio
393.698
289.103
236.905
76.129
49.817
51.421
45.206
Financial autonomy
18.002
23.561
26.945
48.13
58.652
57.381
60.492
Repayment capacity
14.721
11.9
19.241
None
None
None
None
Cash flow / Revenue
4.23%
5.496%
3.245%
None%
None%
None%
None%
Sector positioning
Debt ratio
45.212025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good+6 pts over 3 years
In 2025, the debt ratio of PHARMACIE CROIX D'OR (45.21) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
60.49%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE CROIX D'OR (60.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CROIX D'OR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2022
2023
2024
2025
Operating WCR
163 964 €
-29 784 €
-40 104 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
38
0
0
0
0
0
0
Customer payment term (days)
5
0
0
0
0
0
0
Supplier payment term (days)
31
28
28
0
0
0
0
Positioning of PHARMACIE CROIX D'OR in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE CROIX D'OR is estimated at
4 022 715 €
(range 2 729 833€ - 6 312 194€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2729k€4022k€6312k€
4 022 715 €Range: 2 729 833€ - 6 312 194€
NAF 5 année 2025
Valuation method used
Net Income Multiple
253 238 €
×
15.9x
=4 022 716 €
Range: 2 729 834€ - 6 312 195€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CROIX D'OR with other companies in the same sector:
Frequently asked questions about PHARMACIE CROIX D'OR
What is the revenue of PHARMACIE CROIX D'OR ?
The revenue of PHARMACIE CROIX D'OR in 2019 is 1.3 M€.
Is PHARMACIE CROIX D'OR profitable?
Yes, PHARMACIE CROIX D'OR generated a net profit of 253 k€ in 2025.
Where is the headquarters of PHARMACIE CROIX D'OR ?
The headquarters of PHARMACIE CROIX D'OR is located in PIERRELATTE (26700), in the department Drome.
Where to find the tax return of PHARMACIE CROIX D'OR ?
The tax return of PHARMACIE CROIX D'OR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CROIX D'OR operate?
PHARMACIE CROIX D'OR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart